Benlysta (Belimumab) and Risk of serious Depression and/ or Suicidal ideation or Behavior or self-injury.

​Two Post Marketing Reports, One Fatal, of Progressive Multifocal Leukoencephalopathy (PML) in Patients with Systemic Lupus Erythematosus (SLE) .